Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04VHZ
|
|||
| Drug Name |
Interferon-alpha 2b
|
|||
| Synonyms |
alb-IFN
Click to Show/Hide
|
|||
| Drug Type |
Protein/peptide drug
|
|||
| Indication | Hairy cell leukaemia [ICD-11: 2A82.2; ICD-10: C91.4; ICD-9: 202.4] | Approved | [1] | |
| Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | Phase 1 | [2] | ||
| Therapeutic Class |
Antiviral Agents
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | FDA Approved Drug Products from FDA Official Website. 2019. Application Number: (BLA) 103132. | |||
| REF 2 | ClinicalTrials.gov (NCT04293887) Efficacy and Safety of IFN-2 in the Treatment of Novel Coronavirus Patients. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.